UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 348

Sortiert nach

Lung cancer: current therapies and new targeted treatments

The Lancet (British edition), 2017-01, Vol.389 (10066), p.299-311

2017

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Journal of thoracic oncology, 2020-06, Vol.15 (6), p.914-947

2020

Volltextzugriff (PDF)

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

Molecular cancer research, 2010-09, Vol.8 (9), p.1207-1216

2010

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

Journal of thoracic oncology, 2020-09, Vol.15 (9), p.1434-1448

2020

Volltextzugriff (PDF)

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3552-3559

2008

Volltextzugriff (PDF)

Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-01, Vol.30 (2), p.172-178

2012

Volltextzugriff (PDF)

Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study

Journal of thoracic oncology, 2015-03, Vol.10 (3), p.492-499

2015

Volltextzugriff (PDF)

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4140-4147

2013

Volltextzugriff (PDF)

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2070-2078

2012

Volltextzugriff (PDF)

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

Journal of clinical oncology, 2012-08, Vol.30 (23), p.2829-2836

2012

Volltextzugriff (PDF)

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2018-01, Vol.13 (1), p.124-133

2018

Volltextzugriff (PDF)

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2019-08, Vol.14 (8), p.1458-1471

2019

Volltextzugriff (PDF)

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.47-54

2020

Volltextzugriff (PDF)

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours

European respiratory review, 2023-03, Vol.32 (167), p.220174

2023

Volltextzugriff (PDF)

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy

Journal of clinical oncology, 2010-03, Vol.28 (9), p.1534-1539

2010

Volltextzugriff (PDF)

COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery

Biomedicines, 2022-03, Vol.10 (4), p.776

2022

Volltextzugriff (PDF)

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

OncoTargets and therapy, 2018-01, Vol.11, p.7353-7368

2018

Volltextzugriff (PDF)

MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations

Human pathology, 2014-08, Vol.45 (8), p.1555-1562

2014

Volltextzugriff (PDF)

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-02, Vol.26 (4), p.650-656

2008

Volltextzugriff (PDF)

Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval

Journal of bone oncology, 2022-04, Vol.33, p.100416-100416, Article 100416

2022

Volltextzugriff (PDF)

The Biology of Epidermal Growth Factor Receptor in Lung Cancer

Clinical cancer research, 2004-06, Vol.10 (12), p.4227s-4232s

2004

Volltextzugriff (PDF)

Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3573-3581

2008

Volltextzugriff (PDF)

Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer–American Society of Clinical Oncology CancerLinQ Study

JTO clinical and research reports, 2024-06, Vol.5 (6), p.100592-100592, Article 100592

2024

Volltextzugriff (PDF)

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity

Journal of experimental & clinical cancer research, 2023-05, Vol.42 (1), p.120-120, Article 120

2023

Volltextzugriff (PDF)

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

Modern pathology, 2009-05, Vol.22 (5), p.709-717

2009

Volltextzugriff (PDF)

1 – 25 von 348

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(266)

Publikationsform

Sprache

Englisch
(344)
Japanisch
(37)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(191)
Science & Technology
(191)
Humans
(179)
Oncology
(165)
Male
(101)
Female
(87)
Aged
(85)
Lung Neoplasms - Drug Therapy
(85)
Middle Aged
(78)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(75)
Lung Neoplasms - Pathology
(71)
Hematology, Oncology, And Palliative Medicine
(63)
Biological And Medical Sciences
(53)
Medical Sciences
(52)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(51)
Adult
(50)
Carcinoma, Non-Small-Cell Lung - Pathology
(50)
Prognosis
(50)
Respiratory System
(50)
Lung Cancer
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thoracic Oncology
(43)
Journal Of Clinical Oncology
(42)
Lung Cancer
(21)
Clinical Lung Cancer
(16)
Cancer
(11)
Clinical Cancer Research
(11)
Seminars In Oncology
(10)
Annals Of Oncology
(7)
Critical Reviews In Oncology/hematology
(6)
European Journal Of Cancer
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lung cancer: current therapies and new targeted treatments

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer

Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy

COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer

Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval

The Biology of Epidermal Growth Factor Receptor in Lung Cancer

Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer

Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer–American Society of Clinical Oncology CancerLinQ Study

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

Suchergebnisse filtern